{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:14:16Z","timestamp":1767010456888,"version":"3.48.0"},"reference-count":26,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12997","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:13:28Z","timestamp":1761048808000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Application of pleural effusion cell blocks for immunohistochemistry and EGFR gene mutation testing for advanced lung cancer"],"prefix":"10.3892","volume":"31","author":[{"given":"Shouxiang","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pathology, Weifang\u00a0No.\u00a02 People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Anqiu Hospital of Traditional Chinese Medicine, Weifang, Shandong 262100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang\u00a0No.\u00a02 People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang\u00a0No.\u00a02 People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang\u00a0No.\u00a02 People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weifang\u00a0No.\u00a02 People's Hospital, Weifang, Shandong 261041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"key20251229141225_b1-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semcancer.2023.01.006","article-title":"Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective","volume":"89","author":"Huang","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"key20251229141225_b2-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1055\/s-0042-1757885","article-title":"Lung cancer screening","volume":"43","author":"Lee","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"key20251229141225_b3-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20251229141225_b4-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4110\/in.2017.17.6.378","article-title":"Immunotherapy for non-small-cell lung cancer: Current status and future obstacles","volume":"17","author":"Cho","year":"2017","journal-title":"Immune Netw"},{"key":"key20251229141225_b5-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.3892\/mmr.2018.8922","article-title":"The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with nonsmall cell lung cancer (review)","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Med Rep"},{"issue":"2950751","key":"key20251229141225_b6-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2950751","article-title":"Malignant pleural effusion: Diagnosis and management","volume":"2020","author":"Ferreiro","year":"2020","journal-title":"Can Respir J"},{"issue":"48","key":"key20251229141225_b7-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00909-8","article-title":"New targets in lung cancer (excluding EGFR, ALK, ROS1)","volume":"22","author":"Russo","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"602726","key":"key20251229141225_b8-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.602726","article-title":"Mutation spectrum of EGFR from 21,324 Chinese patients with non-small cell lung cancer (NSCLC) successfully tested by multiple methods in a CAP-accredited laboratory","volume":"27","author":"Mao","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"e36850","key":"key20251229141225_b9-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036850","article-title":"Thoracentesis techniques: A literature review","volume":"103","author":"Mohammed","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"key20251229141225_b10-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MCP.0000000000000593","article-title":"Diagnosis and characterization of malignant effusions through pleural fluid cytological examination","volume":"25","author":"Porcel","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"key20251229141225_b11-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med"},{"key":"key20251229141225_b12-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"534","DOI":"10.20517\/cdr.2022.61","article-title":"Emerging insights to lung cancer drug resistance","volume":"5","author":"Su","year":"2022","journal-title":"Cancer Drug Resist"},{"key":"key20251229141225_b13-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.lungcan.2016.11.022","article-title":"Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin\/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC","volume":"104","author":"Wu","year":"2017","journal-title":"Lung Cancer"},{"key":"key20251229141225_b14-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S1470-2045(13)70355-3","article-title":"Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): A randomised, double-blind phase 3 non-inferiority trial","volume":"14","author":"Shi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"e0142500","key":"key20251229141225_b15-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142500","article-title":"The efficacy and safety of Icotinib in patients with advanced non-small cell lung cancer previously treated with chemotherapy: A single-arm, multi-center, prospective study","volume":"10","author":"Hu","year":"2015","journal-title":"PLoS One"},{"key":"key20251229141225_b16-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","article-title":"NCCN guidelines\u00ae insights: Non-small cell lung cancer, version 2.2023","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"17","key":"key20251229141225_b17-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-022-00248-z","article-title":"Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China","volume":"44","author":"Wang","year":"2022","journal-title":"Genes Environ"},{"issue":"e001492","key":"key20251229141225_b18-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001492","article-title":"Differential clinicopathological features, treatments and outcomes in patients with exon 19 deletion and exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer","volume":"10","author":"Batra","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"key20251229141225_b19-ETM-31-1-12997","first-page":"113","article-title":"Successful treatment of a patient with lung adenocarcinoma harboring compound EGFR gene mutations, G719X and S768I, with afatinib","volume":"45","author":"Kutsuzawa","year":"2020","journal-title":"Tokai J Exp Clin Med"},{"key":"key20251229141225_b20-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.athoracsur.2020.05.041","article-title":"Clinical impacts of EGFR mutation status: Analysis of 5780 surgically resected lung cancer cases","volume":"111","author":"Suda","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"key20251229141225_b21-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/1759-7714.12932","article-title":"Detecting EGFR mutations and ALK\/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples","volume":"10","author":"Yao","year":"2019","journal-title":"Thorac Cancer"},{"issue":"e11116","key":"key20251229141225_b22-ETM-31-1-12997","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011116","article-title":"Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC\/ATS\/ERS classification of lung adenocarcinoma","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key20251229141225_b23-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/1759-7714.12489","article-title":"Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC\/ATS\/ERS classification in Chinese patients","volume":"8","author":"Wang","year":"2017","journal-title":"Thorac Cancer"},{"key":"key20251229141225_b24-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/1759-7714.13577","article-title":"Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution","volume":"11","author":"Li","year":"2020","journal-title":"Thorac Cancer"},{"key":"key20251229141225_b25-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00432-021-03818-w","article-title":"Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients","volume":"148","author":"He","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20251229141225_b26-ETM-31-1-12997","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.7150\/thno.16558","article-title":"Cross-platform comparison of four leading technologies for detecting EGFR mutations in circulating tumor DNA from non-small cell lung carcinoma patient plasma","volume":"7","author":"Xu","year":"2017","journal-title":"Theranostics"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:12:34Z","timestamp":1767010354000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,21]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12997","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"type":"print","value":"1792-0981"},{"type":"electronic","value":"1792-1015"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}